Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) Gross Margin (2020 - 2025)

Celularity has reported Gross Margin over the past 6 years, most recently at 26.12% for Q3 2025.

  • Quarterly results put Gross Margin at 26.12% for Q3 2025, down 3211.0% from a year ago — trailing twelve months through Sep 2025 was 13.36% (down 5084.0% YoY), and the annual figure for FY2024 was 72.36%, up 4269.0%.
  • Gross Margin for Q3 2025 was 26.12% at Celularity, up from 8.61% in the prior quarter.
  • Over the last five years, Gross Margin for CELU hit a ceiling of 93.99% in Q3 2021 and a floor of 967.3% in Q4 2024.
  • Median Gross Margin over the past 5 years was 68.9% (2025), compared with a mean of 10.09%.
  • Biggest five-year swings in Gross Margin: soared 21287bps in 2023 and later tumbled -98796bps in 2024.
  • Celularity's Gross Margin stood at 90.71% in 2021, then tumbled by -312bps to 192.2% in 2022, then surged by 111bps to 20.67% in 2023, then plummeted by -4781bps to 967.3% in 2024, then surged by 103bps to 26.12% in 2025.
  • The last three reported values for Gross Margin were 26.12% (Q3 2025), 8.61% (Q2 2025), and 68.9% (Q1 2025) per Business Quant data.